Pharma Journalist -

Amicus Therapeutics, Inc. has entered into a strategic manufacturing agreement with Paragon Gene Therapy, a unit of Catalent Biologics, for clinical manufacturing capabilities and…
Read More...

DicernaTMPharmaceuticals announced it submitted a Clinical Trial Authorization (CTA) application to the Swedish Medical Products Agency (MPA) last week to conduct a first-in-human Phase…
Read More...

Sandoz announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with activating…
Read More...

Asieris MediTech Co, Ltd (Asieris), a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and…
Read More...

London, July 2nd 2019, Cancer Research UK, the world's largest independent funder of cancer research, announced a strategic partnership with SV Health Investors (SV), a leading life…
Read More...

19th Pharmacovigilance 2019 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.  The…
Read More...

Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, announced the achievement of pre-clinical proof-of-concept based on…
Read More...

Lonza announced its entry into a binding contractual commitment for the purchase of a sterile drug product fill & finish facility from Novartis. The closing is expected to take…
Read More...

PTC Therapeutics, Inc. and Odylia Therapeutics announced a strategic collaboration to develop novel gene therapies in rare inherited retinal diseases (IRDs) utilizing the Anc80 vector…
Read More...

Boehringer Ingelheim and Yuhan Corporation announced a collaboration and license agreement for the development of a first-in-class dual agonist for the treatment of NASH and related…
Read More...